Autologous 4-1BB selected tumor infiltrating lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011316
A preparation of autologous tumor infiltrating lymphocytes (TILs) expressing the co-stimulatory signaling domain 4-1BB (CD137), with potential antineoplastic activity. TILs are isolated from a patient's tumor and those expressing 4-1BB are selected for expansion in vitro. Upon re-infusion into the patient, the 4-1BB-expressing TILs re-infiltrate the tumor to initiate tumor cell lysis. 4-1BB, a member of the tumor necrosis factor (TNF) receptor superfamily, enhances TIL survival and antitumor cytolytic activity.
| Identifier | MLC-T-ONC-011316 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous 4-1BB selected TILs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011316",
"term": "Autologous 4-1BB selected tumor infiltrating lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous tumor infiltrating lymphocytes (TILs) expressing the co-stimulatory signaling domain 4-1BB (CD137), with potential antineoplastic activity. TILs are isolated from a patient's tumor and those expressing 4-1BB are selected for expansion in vitro. Upon re-infusion into the patient, the 4-1BB-expressing TILs re-infiltrate the tumor to initiate tumor cell lysis. 4-1BB, a member of the tumor necrosis factor (TNF) receptor superfamily, enhances TIL survival and antitumor cytolytic activity.",
"synonyms": [
"autologous 4-1BB selected TILs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-4-1bb-selected-tumor-infiltrating-lymphocytes/"
}
Record 2,648 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.